Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dorota Wierzbicka"'
Publikováno v:
Acta Universitatis Lodziensis. Folia Librorum, Vol 1, Iss 30, Pp 47-55 (2020)
Narodowe Centrum Nauki we wrześniu 2018 r. zadeklarowało udział w realizacji Planu S, który przewiduje, że od 1 stycznia 2020 r. wszystkie publikacje naukowe powstałe z udziałem finansowania ze środków publicznych muszą być publikowane w c
Externí odkaz:
https://doaj.org/article/ffdc49d024af4bc0aa75de8117351d23
Publikováno v:
Acta Universitatis Lodziensis. Folia Librorum, Vol 1, Iss 30, Pp 47-55 (2020)
In September 2018 the National Science Center declared to participate in the implementation of the S Plan, which provides that since January 1, 2020, all academic publications created as a result of public funding must be published in Open Access jou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aba594f91e744db0733da152929096c
https://hdl.handle.net/11089/37685
https://hdl.handle.net/11089/37685
Publikováno v:
Journal of Metabolic Syndrome.
Objective: To examine maternal serum levels of leptin at 11-13 weeks gestation in normal and pathological pregnancies. Methods: Serum leptin, PAPP-A and uterine artery pulsatility index (PI) at 11-13 weeks were measured in 480 singleton pregnancies,
Publikováno v:
The journal of maternal-fetalneonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 24(7)
The presence of the uterine leiomyomas may change the concentrations of the screening serum markers and so after the risk calculation of the fetal chromosomal abnormalities.To estimate the influence of the uterine leiomyomas on the first and second t
Autor:
Piotr, Sieroszewski, Łukasz, Bober, Dorota, Wierzbicka, Elzbieta, Baś-Budecka, Małgorzata, Perenc
Publikováno v:
Ginekologia polska. 80(12)
Uterine myomas may change the concentrations of the screening serum markers and therefore alter the risk calculation of the fetal chromosomal abnormalities. An increased risk leads to invasive diagnostics procedures which in these cases can often be
Autor:
Krzysztof Jamroziak, Piotr Smolewski, Dorota Wierzbicka, Barbara Cebula, Tadeusz Robak, Anna Linke, Mikhail V. Blagosklonny, Zbigniew Darzynkiewicz
Publikováno v:
Publons
Background: The mTOR kinase inhibitor, rapamycin (RAPA), inhibits cell growth by G1 phase cell cycle arrest. RAPA-induced cytotoxicity against acute lymphoblastic leukemia (ALL) cells was recently reported. Aim: We investigated cytotoxicity of RAPA a